Sign in

CIK 0001789972

  • Non-accelerated filer
  • Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813879991
Phone
+1 617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Open-market sale Director sold 120,592 shares at an average $29.29 ($3,531,820)
  2. 4 Open-market sale Zawel Leigh sold 28,118 shares at $29.00 ($815,422)
  3. 4 Open-market sale Michaelson Jennifer sold 4,000 shares at an average $27.66 ($110,648)
  4. 4 Open-market sale 10% owner sold 2,510 shares at $29.05 ($72,916)
  5. 4 Open-market sale Director sold 2,857 shares at $29.05 ($82,996)
  6. 4 Open-market sale Zawel Leigh sold 28,118 shares at an average $26.77 ($752,850)
  7. 4 Open-market buy 10% owner bought 300,000 shares at $21.00 ($6,300,000)
  8. 4 Open-market buy Director bought 300,000 shares at $21.00 ($6,300,000)
  9. 3/A Insider 3/A
  10. 4 Open-market buy Director bought 200,000 shares at $21.00 ($4,200,000)
  11. 4 Open-market buy President and CEO bought 2,500 shares at $21.00 ($52,500)
  12. 4 Open-market buy Chief Financial Officer bought 2,250 shares at $21.00 ($47,250)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 12 of 13 · 253 filings